Covid-19 Variant Shot From Sanofi, GSK Shows Strong Response to Omicron in Studies

Two new studies from Sanofi and GSK add to promising signs that Covid-19 variant vaccines can broaden immune response

If you’ve had Covid before, why can you get it again? WSJ’s Daniela Hernandez explains what the possibility of reinfections means for the future of public-health policy and the Covid-19 pandemic.

Illustration: David FangA Covid-19 vaccine developed by Sanofi SA and GSK PLC to target the Beta strain of the virus produced a stronger antibody response against variants of Omicron when given as a booster compared with certain first-generation shots, two studies have found.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

WSJhealth /  🏆 413. in US

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Ringo Starr Postpones Summer Tour Dates After All Starr Band Members Test Positive for COVID-19“We are so sorry to let the fans down,” the legendary Beatles drummer said.
Read more »

Sleeping issues linked to long-haul COVID-19Medical research points to sleeping issues as one of the long term effects of COVID-19. A doctor explains why.
Read more »

Research behind COVID-19 vaccines reaps close to $1 billion in royalties for PennPenn officials said they are plowing the money back into early-stage scientific research.
Read more »

Cross Country Memorial Honors Haltom City Officer Who Died of COVID-19A nationwide effort to remember fallen members of law enforcement arrived in Haltom City to honor one of its own.
Read more »

US: Pfizer COVID-19 shot appears effective for kids under 5WASHINGTON (AP) — Federal health officials said Sunday that kid-sized doses of Pfizer’s COVID-19 vaccines appear to be safe and effective for kids under 5, a key step toward a long-awaited decision to begin vaccinating the youngest American children .
Read more »

US: Pfizer COVID-19 shot appears effective for kids under 5Federal health officials said Sunday that kid-sized doses of Pfizer’s COVID-19 vaccines appear to be safe and effective for kids under 5, a key step toward a long-awaited decision to begin vaccinating the youngest American children.
Read more »